共查询到20条相似文献,搜索用时 31 毫秒
1.
Risk of swallowing‐related chest infections in patients with nasopharyngeal carcinoma treated with definitive intensity‐modulated radiotherapy 下载免费PDF全文
Jiaqing Xiong BEng Gita Krishnaswamy MSc MEng Sharon Raynor MSc Kwok Seng Loh FRCS Andrea Lay Hoon Kwa PharmD Chwee Ming Lim MRCS MMed 《Head & neck》2016,38(Z1):E1660-E1665
2.
3.
4.
5.
6.
Impact of selective neck dissection on chronic dysphagia after chemo‐intensity‐modulated radiotherapy for oropharyngeal carcinoma 下载免费PDF全文
Katherine A. Hutcheson PhD Amal R. Abualsamh BDS MS Alejandro Sosa DMD Randal S. Weber MD Beth M. Beadle MD PhD Erich M. Sturgis MD MPH Jan S. Lewin PhD 《Head & neck》2016,38(6):886-893
7.
8.
Peter K. M. Ku Floyd Christopher Holsinger Jason Y. K. Chan Zenon W. C. Yeung Becky Y. T. Chan Michael C. F. Tong Heather M. Starmer 《Head & neck》2020,42(7):1491-1496
The global pandemic of 2019 novel coronavirus disease (COVID‐19) has tremendously altered routine medical service provision and imposed unprecedented challenges to the health care system. This impacts patients with dysphagia complications caused by head and neck cancers. As this pandemic of COVID‐19 may last longer than severe acute respiratory syndrome (SARS) in 2003, a practical workflow for managing dysphagia is crucial to ensure a safe and efficient practice to patients and health care personnel. This document provides clinical practice guidelines based on available evidence to date to balance the risks of SARS‐CoV‐2 exposure with the risks associated with dysphagia. Critical considerations include reserving instrumental assessments for urgent cases only, optimizing the noninstrumental swallowing evaluation, appropriate use of personal protective equipment (PPE), and use of telehealth when appropriate. Despite significant limitations in clinical service provision during the pandemic of COVID‐19, a safe and reasonable dysphagia care pathway can still be implemented with modifications of setup and application of newer technologies. 相似文献
9.
Impact of xerostomia on dysphagia after chemotherapy–intensity‐modulated radiotherapy for oropharyngeal cancer: Prospective longitudinal study 下载免费PDF全文
Jeffrey M. Vainshtein MD Stuart Samuels MD PhD Yebin Tao MSc Teresa Lyden MA CCC‐SLP Marc Haxer MA CCC‐SLP Matthew Spector MD Matthew Schipper PhD Avraham Eisbruch MD 《Head & neck》2016,38(Z1):E1605-E1612
10.
11.
12.
13.
14.
15.
B. J. Levvey M. Harkess P. Hopkins D. Chambers C. Merry A. R. Glanville G. I. Snell 《American journal of transplantation》2012,12(9):2406-2413
Donation‐after‐Determination‐of‐Cardiac‐Death (DDCD) donor lungs can potentially increase the pool of lungs available for Lung Transplantation (LTx). This paper presents the 5‐year results for Maastricht category III DDCD LTx undertaken by the multicenter Australian National DDCD LTx Collaborative. The Collaborative was developed to facilitate interaction with the Australian Organ Donation Authority, standardization of definitions, guidelines, education and audit processes. Between 2006 and 2011 there were 174 actual DDCD category III donors (with an additional 37 potentially suitable donors who did not arrest in the mandated 90 min postwithdrawal window), of whom 71 donated lungs for 70 bilateral LTx and two single LTx. In 2010 this equated to an “extra” 28% of donors utilized for LTx. Withdrawal to pulmonary arterial flush was a mean of 35.2 ± 4.0 min (range 18–89). At 24 h, the incidence of grade 3 primary graft dysfunction was 8.5%[median PaO2/FiO2 ratio 315 (range 50–507)]. Overall the incidence of grade 3 chronic rejections was 5%. One‐ and 5‐year actuarial survival was 97% and 90%, versus 90% and 61%, respectively, for 503 contemporaneous brain‐dead donor lung transplants. Category III DDCD LTx therefore provides a significant, practical, additional quality source of transplantable lungs. 相似文献
16.
Helical intensity‐modulated radiotherapy with concurrent chemotherapy for oropharyngeal squamous cell carcinoma: A prospective investigation of acute swallowing and toxicity patterns 下载免费PDF全文
Laura B. Moroney BSpPath Jennifer Helios BSpPath Elizabeth C. Ward PhD Jane Crombie BSpPath Anita Pelecanos BHSc Clare L. Burns PhD Ann‐Louise Spurgin BSpPath Claire Blake BHSc Lizbeth Kenny AO MBBS FRANZCR Benjamin Chua MBBS FRANZCR Brett G. M. Hughes MBBS FRACP 《Head & neck》2018,40(9):1955-1966
17.
Strategies to reduce long‐term postchemoradiation dysphagia in patients with head and neck cancer: An evidence‐based review 下载免费PDF全文
Vinidh Paleri Justin W. G. Roe Primo Strojan June Corry Vincent Grgoire Marc Hamoir Avraham Eisbruch William M. Mendenhall Carl E. Silver Alessandra Rinaldo Robert P. Takes Alfio Ferlito 《Head & neck》2014,36(3):431-443
18.
Relationship between swallow‐specific quality of life and fiber‐optic endoscopic evaluation of swallowing findings in patients with head and neck cancer 下载免费PDF全文
Michelle Florie MD Laura Baijens MD PhD Bernd Kremer MD PhD Kenneth Kross MD PhD Martin Lacko MD PhD Femke Verhees MD Bjorn Winkens PhD 《Head & neck》2016,38(Z1):E1848-E1856
19.
Aspiration pneumonia after chemo–intensity‐modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia‐related predictors 下载免费PDF全文
Klaudia U. Hunter MD Oliver E. Lee PhD Teresa H. Lyden MA Marc J. Haxer MA Felix Y. Feng MD Mathew Schipper PhD Francis Worden MD Mark E. Prince MD Scott A. McLean MD Gregory T. Wolf MD Carol R. Bradford MD Douglas B. Chepeha MD Avraham Eisbruch MD 《Head & neck》2014,36(1):120-125
20.